Skip to content

Ablative fractional carbon-dioxide laser combined with intense pulsed light for the treatment of photoaging Skin in Chinese Population- a split-face study

Ablative fractional carbon-dioxide laser combined with intense pulsed light for the treatment of photoaging Skin in Chinese Population- a split-face study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011681
Enrollment
Unknown
Registered
2017-06-17
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial photoaging

Interventions

1:The participants received IPL alone in the left side of the face or in combination with AFL in the right side of the face.
2:The participants received IPL alone in the right side of the face or in combination with AFL in the left side of the face.

Sponsors

Beijing Friendship Hospital affiliated to the Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: The Eligible subjects in the study were women between 40-60 years; had Fitzpatrick skin type III and IV; and in a generally good health condition.

Exclusion criteria

Exclusion criteria: 1) recent exposure to the sun; 2) patients with light sensitivity or porphyria who were unable to undergo light therapy; 3) progressive psoriasis, vitiligo, or keloids and hypertrophic scars; 4) autoimmune diseases or serious systemic diseases; 5) malignant tumors or precancerous lesion in the skin or other organs; 6) damage or infection in the skin for light therapy; 7) herpes simplex infection in the previous 6 months; 8) the use of photosensitive drugs or topical retinoids in the previous four weeks; 9) the use of systemic corticosteroids or oral retinoids in the previous 6 months; 10) facial laser photon beauty or similar treatments in the previous 6 months; 11) facial filling or wire implantation; 12) the use of oral contraceptives; and 13) pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
transepidermal water loss;hydration;skin elasticity;spots;texture;pore size;Ultraviolet spots;brown spots;red area;wrinkles;

Countries

China

Contacts

Public ContactLi Wang

Beijing Friendship Hospital affiliated to the Capital Medical University

wl8866@sohu.com+86 18610721066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026